PEG‐poly(L‐lysine)‐based polymeric micelle MRI contrast agent: Feasibility study of a Gd‐micelle contrast agent for MR lymphography

Purpose To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)‐b‐poly(L‐lysine‐DOTA) (Gd‐micelle) as a contrast agent for magnetic resonance lymphography (MRL). Materials and Methods Twenty‐four female BALB/c mice were randomly divided into four groups of six mice each. Am...

Full description

Saved in:
Bibliographic Details
Published inJournal of magnetic resonance imaging Vol. 47; no. 1; pp. 238 - 245
Main Authors Akai, Hiroyuki, Shiraishi, Kouichi, Yokoyama, Masayuki, Yasaka, Koichiro, Nojima, Masanori, Inoue, Yusuke, Abe, Osamu, Ohtomo, Kuni, Kiryu, Shigeru
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)‐b‐poly(L‐lysine‐DOTA) (Gd‐micelle) as a contrast agent for magnetic resonance lymphography (MRL). Materials and Methods Twenty‐four female BALB/c mice were randomly divided into four groups of six mice each. Among them, mice of two groups were injected of complete Freund's adjuvant to obtain inflamed lymph nodes. We subcutaneously injected 0.5 μmol Gd per mouse of Gd‐micelle or gadofluorine P in the right rear footpad. Identical 3D T1‐weighted gradient‐echo imaging (1T MRI system) were subsequently obtained to create time–intensity curves of the right popliteal, sacral, and lumbar‐aortic lymph nodes and to measure the contrast ratios (CRs). The peak CR, area under the curve (AUC), and elimination half‐life (T1/2) of CR of the popliteal lymph node were assessed by two‐way factorial analysis of variance. We also performed a qualitative assessment of normal and inflamed lymph node at three timepoints. Results The mean peak CR of Gd‐micelle was 2.64 and 1.89 for gadofluorine P in normal mice, and 3.48 and 2.73 in the inflamed lymph node. Statistically, peak CR was higher for Gd‐micelle (P = 0.004). In addition, the AUC was larger (P < 0.001) and T1/2 was longer (P < 0.001) for Gd‐micelle. In qualitative assessment, Gd‐micelle demonstrated the same or higher scores in every lymph node, and demonstrated a higher score in lumbar‐aortic lymph node of a 360‐minute image (P = 0.006) and in inflamed lymph node of a 360‐minute image (P = 0.009). Conclusion Compared to gadofluorine P, Gd‐micelle showed higher and more prolonged enhancement in MRL imaging in normal and inflamed lymph nodes. Level of Evidence: 1 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2018;47:238–245.
AbstractList Purpose To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)-b-poly(L-lysine-DOTA) (Gd-micelle) as a contrast agent for magnetic resonance lymphography (MRL). Materials and Methods Twenty-four female BALB/c mice were randomly divided into four groups of six mice each. Among them, mice of two groups were injected of complete Freund's adjuvant to obtain inflamed lymph nodes. We subcutaneously injected 0.5 µmol Gd per mouse of Gd-micelle or gadofluorine P in the right rear footpad. Identical 3D T1-weighted gradient-echo imaging (1T MRI system) were subsequently obtained to create time-intensity curves of the right popliteal, sacral, and lumbar-aortic lymph nodes and to measure the contrast ratios (CRs). The peak CR, area under the curve (AUC), and elimination half-life (T1/2) of CR of the popliteal lymph node were assessed by two-way factorial analysis of variance. We also performed a qualitative assessment of normal and inflamed lymph node at three timepoints. Results The mean peak CR of Gd-micelle was 2.64 and 1.89 for gadofluorine P in normal mice, and 3.48 and 2.73 in the inflamed lymph node. Statistically, peak CR was higher for Gd-micelle (P = 0.004). In addition, the AUC was larger (P < 0.001) and T1/2 was longer (P < 0.001) for Gd-micelle. In qualitative assessment, Gd-micelle demonstrated the same or higher scores in every lymph node, and demonstrated a higher score in lumbar-aortic lymph node of a 360-minute image (P = 0.006) and in inflamed lymph node of a 360-minute image (P = 0.009). Conclusion Compared to gadofluorine P, Gd-micelle showed higher and more prolonged enhancement in MRL imaging in normal and inflamed lymph nodes. Level of Evidence: 1 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2018;47:238-245.
PURPOSETo investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)-b-poly(L-lysine-DOTA) (Gd-micelle) as a contrast agent for magnetic resonance lymphography (MRL).MATERIALS AND METHODSTwenty-four female BALB/c mice were randomly divided into four groups of six mice each. Among them, mice of two groups were injected of complete Freund's adjuvant to obtain inflamed lymph nodes. We subcutaneously injected 0.5 μmol Gd per mouse of Gd-micelle or gadofluorine P in the right rear footpad. Identical 3D T1 -weighted gradient-echo imaging (1T MRI system) were subsequently obtained to create time-intensity curves of the right popliteal, sacral, and lumbar-aortic lymph nodes and to measure the contrast ratios (CRs). The peak CR, area under the curve (AUC), and elimination half-life (T1/2 ) of CR of the popliteal lymph node were assessed by two-way factorial analysis of variance. We also performed a qualitative assessment of normal and inflamed lymph node at three timepoints.RESULTSThe mean peak CR of Gd-micelle was 2.64 and 1.89 for gadofluorine P in normal mice, and 3.48 and 2.73 in the inflamed lymph node. Statistically, peak CR was higher for Gd-micelle (P = 0.004). In addition, the AUC was larger (P < 0.001) and T1/2 was longer (P < 0.001) for Gd-micelle. In qualitative assessment, Gd-micelle demonstrated the same or higher scores in every lymph node, and demonstrated a higher score in lumbar-aortic lymph node of a 360-minute image (P = 0.006) and in inflamed lymph node of a 360-minute image (P = 0.009).CONCLUSIONCompared to gadofluorine P, Gd-micelle showed higher and more prolonged enhancement in MRL imaging in normal and inflamed lymph nodes.LEVEL OF EVIDENCE1 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2018;47:238-245.
Purpose To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)‐b‐poly(L‐lysine‐DOTA) (Gd‐micelle) as a contrast agent for magnetic resonance lymphography (MRL). Materials and Methods Twenty‐four female BALB/c mice were randomly divided into four groups of six mice each. Among them, mice of two groups were injected of complete Freund's adjuvant to obtain inflamed lymph nodes. We subcutaneously injected 0.5 μmol Gd per mouse of Gd‐micelle or gadofluorine P in the right rear footpad. Identical 3D T 1 ‐weighted gradient‐echo imaging (1T MRI system) were subsequently obtained to create time–intensity curves of the right popliteal, sacral, and lumbar‐aortic lymph nodes and to measure the contrast ratios (CRs). The peak CR, area under the curve (AUC), and elimination half‐life ( T 1/2 ) of CR of the popliteal lymph node were assessed by two‐way factorial analysis of variance. We also performed a qualitative assessment of normal and inflamed lymph node at three timepoints. Results The mean peak CR of Gd‐micelle was 2.64 and 1.89 for gadofluorine P in normal mice, and 3.48 and 2.73 in the inflamed lymph node. Statistically, peak CR was higher for Gd‐micelle ( P = 0.004). In addition, the AUC was larger ( P < 0.001) and T 1/2 was longer ( P < 0.001) for Gd‐micelle. In qualitative assessment, Gd‐micelle demonstrated the same or higher scores in every lymph node, and demonstrated a higher score in lumbar‐aortic lymph node of a 360‐minute image ( P = 0.006) and in inflamed lymph node of a 360‐minute image ( P = 0.009). Conclusion Compared to gadofluorine P, Gd‐micelle showed higher and more prolonged enhancement in MRL imaging in normal and inflamed lymph nodes. Level of Evidence: 1 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2018;47:238–245.
Purpose To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)‐b‐poly(L‐lysine‐DOTA) (Gd‐micelle) as a contrast agent for magnetic resonance lymphography (MRL). Materials and Methods Twenty‐four female BALB/c mice were randomly divided into four groups of six mice each. Among them, mice of two groups were injected of complete Freund's adjuvant to obtain inflamed lymph nodes. We subcutaneously injected 0.5 μmol Gd per mouse of Gd‐micelle or gadofluorine P in the right rear footpad. Identical 3D T1‐weighted gradient‐echo imaging (1T MRI system) were subsequently obtained to create time–intensity curves of the right popliteal, sacral, and lumbar‐aortic lymph nodes and to measure the contrast ratios (CRs). The peak CR, area under the curve (AUC), and elimination half‐life (T1/2) of CR of the popliteal lymph node were assessed by two‐way factorial analysis of variance. We also performed a qualitative assessment of normal and inflamed lymph node at three timepoints. Results The mean peak CR of Gd‐micelle was 2.64 and 1.89 for gadofluorine P in normal mice, and 3.48 and 2.73 in the inflamed lymph node. Statistically, peak CR was higher for Gd‐micelle (P = 0.004). In addition, the AUC was larger (P < 0.001) and T1/2 was longer (P < 0.001) for Gd‐micelle. In qualitative assessment, Gd‐micelle demonstrated the same or higher scores in every lymph node, and demonstrated a higher score in lumbar‐aortic lymph node of a 360‐minute image (P = 0.006) and in inflamed lymph node of a 360‐minute image (P = 0.009). Conclusion Compared to gadofluorine P, Gd‐micelle showed higher and more prolonged enhancement in MRL imaging in normal and inflamed lymph nodes. Level of Evidence: 1 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2018;47:238–245.
To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)-b-poly(L-lysine-DOTA) (Gd-micelle) as a contrast agent for magnetic resonance lymphography (MRL). Twenty-four female BALB/c mice were randomly divided into four groups of six mice each. Among them, mice of two groups were injected of complete Freund's adjuvant to obtain inflamed lymph nodes. We subcutaneously injected 0.5 μmol Gd per mouse of Gd-micelle or gadofluorine P in the right rear footpad. Identical 3D T -weighted gradient-echo imaging (1T MRI system) were subsequently obtained to create time-intensity curves of the right popliteal, sacral, and lumbar-aortic lymph nodes and to measure the contrast ratios (CRs). The peak CR, area under the curve (AUC), and elimination half-life (T ) of CR of the popliteal lymph node were assessed by two-way factorial analysis of variance. We also performed a qualitative assessment of normal and inflamed lymph node at three timepoints. The mean peak CR of Gd-micelle was 2.64 and 1.89 for gadofluorine P in normal mice, and 3.48 and 2.73 in the inflamed lymph node. Statistically, peak CR was higher for Gd-micelle (P = 0.004). In addition, the AUC was larger (P < 0.001) and T was longer (P < 0.001) for Gd-micelle. In qualitative assessment, Gd-micelle demonstrated the same or higher scores in every lymph node, and demonstrated a higher score in lumbar-aortic lymph node of a 360-minute image (P = 0.006) and in inflamed lymph node of a 360-minute image (P = 0.009). Compared to gadofluorine P, Gd-micelle showed higher and more prolonged enhancement in MRL imaging in normal and inflamed lymph nodes. 1 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2018;47:238-245.
Author Akai, Hiroyuki
Ohtomo, Kuni
Shiraishi, Kouichi
Abe, Osamu
Yokoyama, Masayuki
Inoue, Yusuke
Kiryu, Shigeru
Nojima, Masanori
Yasaka, Koichiro
Author_xml – sequence: 1
  givenname: Hiroyuki
  surname: Akai
  fullname: Akai, Hiroyuki
  organization: Institute of Medical Science, University of Tokyo
– sequence: 2
  givenname: Kouichi
  surname: Shiraishi
  fullname: Shiraishi, Kouichi
  organization: Research Center for Medical Science, Jikei University School of Medicine
– sequence: 3
  givenname: Masayuki
  surname: Yokoyama
  fullname: Yokoyama, Masayuki
  organization: Research Center for Medical Science, Jikei University School of Medicine
– sequence: 4
  givenname: Koichiro
  surname: Yasaka
  fullname: Yasaka, Koichiro
  organization: Institute of Medical Science, University of Tokyo
– sequence: 5
  givenname: Masanori
  surname: Nojima
  fullname: Nojima, Masanori
  organization: Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo
– sequence: 6
  givenname: Yusuke
  surname: Inoue
  fullname: Inoue, Yusuke
  organization: Kitasato University School of Medicine
– sequence: 7
  givenname: Osamu
  surname: Abe
  fullname: Abe, Osamu
  organization: Graduate School of Medicine, University of Tokyo
– sequence: 8
  givenname: Kuni
  surname: Ohtomo
  fullname: Ohtomo, Kuni
  organization: International University of Health and Welfare
– sequence: 9
  givenname: Shigeru
  surname: Kiryu
  fullname: Kiryu, Shigeru
  email: kiryu-tky@umin.ac.jp
  organization: Institute of Medical Science, University of Tokyo
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28419613$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1L3UAUhgex-L3xB5SBbmwhOp_JjDsRvbVcUUTXw9zkROeSZOJMQsmu-276G_tLOrdXBbvo6rxwnvNw4N1Fm53vAKFDSo4pIexk2QZ3zGQhyAbaoZKxjEmVb6ZMJM-oIsU22o1xSQjRWsgttM2UoDqnfAf9vL2Y_f7xq_fNdDRPoZmi6-BzSgsbocKrRQvBlbh1JTQN4Ou7K1z6bgg2Dtg-Qjec4kuw0S1c44YJx2GsJuxrbPGsSp7Xu_c3uPYhqXCy90_-Mdj-adpHH2rbRDh4mXvo4fLi_vxrNr-ZXZ2fzbNSSE2yBZFgacUUUKWIpVoXtRC1FlrnpVAV6MQprgvOZU4rLgWV3NpaMF4SVed8Dx2tvX3wzyPEwbQurp60HfgxmqTVRaE10Qn99A-69GPo0neG6kIKxTgrEvVlTZXBxxigNn1wrQ2TocSsKjKriszfihL88UU5Llqo3tDXThJA18B318D0H5X5lrpYS_8AJGGhDA
CitedBy_id crossref_primary_10_1016_j_jmir_2019_09_006
crossref_primary_10_4155_fmc_2017_0215
crossref_primary_10_1039_D0SC04750C
crossref_primary_10_1007_s00330_023_09423_4
crossref_primary_10_1039_C8CC08875F
crossref_primary_10_1039_D0TB00721H
crossref_primary_10_1039_D0CC04372A
crossref_primary_10_1002_jbio_202100149
crossref_primary_10_1016_j_jconrel_2021_05_029
crossref_primary_10_1021_acsbiomaterials_0c01076
crossref_primary_10_1016_j_bioactmat_2020_12_001
crossref_primary_10_1007_s10334_019_00738_2
crossref_primary_10_1016_j_cis_2020_102213
crossref_primary_10_1615_CritRevTherDrugCarrierSyst_2023045298
Cites_doi 10.1016/S0169-409X(98)00099-4
10.1016/j.jvs.2007.01.023
10.1038/nbt920
10.1148/radiol.2203010090
10.1002/cncr.11464
10.3748/wjg.v21.i19.5831
10.1089/lrb.2008.1008
10.1002/jmri.1880070111
10.1016/j.ejrad.2005.12.044
10.2463/mrms.11.99
10.1148/radiology.218.3.r01fe21664
10.1148/radiol.2302021380
10.1097/00004728-200307000-00036
10.1016/j.jconrel.2009.01.010
10.1097/01.rli.0000065423.05038.88
10.1186/s12885-015-1255-4
10.1016/j.jconrel.2010.08.018
10.1016/j.mri.2009.10.005
10.1002/jmri.22422
10.1097/00004424-200302000-00002
ContentType Journal Article
Copyright 2017 International Society for Magnetic Resonance in Medicine
2017 International Society for Magnetic Resonance in Medicine.
2018 International Society for Magnetic Resonance in Medicine
Copyright_xml – notice: 2017 International Society for Magnetic Resonance in Medicine
– notice: 2017 International Society for Magnetic Resonance in Medicine.
– notice: 2018 International Society for Magnetic Resonance in Medicine
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QO
7TK
8FD
FR3
K9.
P64
7X8
DOI 10.1002/jmri.25740
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Biotechnology Research Abstracts
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
CrossRef

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1522-2586
EndPage 245
ExternalDocumentID 10_1002_jmri_25740
28419613
JMRI25740
Genre article
Journal Article
GroupedDBID ---
-DZ
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HDBZQ
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TWZ
UB1
V2E
V8K
V9Y
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XV2
ZXP
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QO
7TK
8FD
FR3
K9.
P64
7X8
ID FETCH-LOGICAL-c4590-b05ea1d28e1880a1997f44f94996c48de9c45839733561d354153aaf423c08f63
IEDL.DBID DR2
ISSN 1053-1807
IngestDate Fri Aug 16 03:01:14 EDT 2024
Thu Oct 10 22:59:29 EDT 2024
Fri Aug 23 02:04:56 EDT 2024
Sat Sep 28 08:38:46 EDT 2024
Sat Aug 24 00:59:48 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords inflammation
MR lymphography
contrast agent
Language English
License 2017 International Society for Magnetic Resonance in Medicine.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4590-b05ea1d28e1880a1997f44f94996c48de9c45839733561d354153aaf423c08f63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmri.25740
PMID 28419613
PQID 1975482327
PQPubID 1006400
PageCount 8
ParticipantIDs proquest_miscellaneous_1889779909
proquest_journals_1975482327
crossref_primary_10_1002_jmri_25740
pubmed_primary_28419613
wiley_primary_10_1002_jmri_25740_JMRI25740
PublicationCentury 2000
PublicationDate January 2018
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: January 2018
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Nashville
PublicationSubtitle JMRI
PublicationTitle Journal of magnetic resonance imaging
PublicationTitleAlternate J Magn Reson Imaging
PublicationYear 2018
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2004; 22
2001; 220
2015; 15
2004; 230
2010; 28
2010; 148
1986; 46
2006; 58
1999; 37
2015; 21
2011; 33
2007
2003; 38
2003; 27
2008; 6
2001; 218
2014; 9
2007; 45
2012; 11
2009; 136
2003; 98
1997; 7
e_1_2_5_15_1
e_1_2_5_14_1
e_1_2_5_17_1
e_1_2_5_9_1
e_1_2_5_16_1
e_1_2_5_8_1
e_1_2_5_11_1
e_1_2_5_7_1
e_1_2_5_10_1
e_1_2_5_6_1
e_1_2_5_13_1
e_1_2_5_21_1
e_1_2_5_5_1
e_1_2_5_12_1
e_1_2_5_22_1
e_1_2_5_4_1
e_1_2_5_3_1
Matsumura Y (e_1_2_5_23_1) 1986; 46
e_1_2_5_2_1
e_1_2_5_19_1
e_1_2_5_18_1
Nehoff H (e_1_2_5_24_1) 2014; 9
e_1_2_5_20_1
References_xml – volume: 46
  start-page: 6387
  year: 1986
  end-page: 6392
  article-title: A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
  publication-title: Cancer Res
– start-page: 238
  year: 2007
  end-page: 239
– volume: 22
  start-page: 93
  year: 2004
  end-page: 97
  article-title: Near‐infrared fluorescent type II quantum dots for sentinel lymph node mapping
  publication-title: Nat Biotechnol
– volume: 136
  start-page: 14
  year: 2009
  end-page: 20
  article-title: Preparation and in vivo imaging of PEG‐poly(L‐lysine)‐based polymeric micelle MRI contrast agents
  publication-title: J Control Release
– volume: 38
  start-page: 358
  year: 2003
  end-page: 365
  article-title: Sentinel node detection using contrast‐enhanced power Doppler ultrasound lymphography
  publication-title: Invest Radiol
– volume: 230
  start-page: 543
  year: 2004
  end-page: 552
  article-title: Breast sentinel lymph node mapping at CT lymphography with iopamidol: preliminary experience
  publication-title: Radiology
– volume: 7
  start-page: 75
  year: 1997
  end-page: 81
  article-title: Iron oxide‐enhanced MR lymphography: the evaluation of cervical lymph node metastases in head and neck cancer
  publication-title: J Magn Reson Imaging
– volume: 38
  start-page: 73
  year: 2003
  end-page: 84
  article-title: Visualization of breast lymphatic pathways with an indirect computed tomography lymphography using a nonionic monometric contrast medium iopamidol: preliminary results
  publication-title: Invest Radiol
– volume: 220
  start-page: 816
  year: 2001
  end-page: 821
  article-title: Interstitial MR lymphography with gadoterate meglumine: initial experience in humans
  publication-title: Radiology
– volume: 33
  start-page: 490
  year: 2011
  end-page: 497
  article-title: Interstitial MR lymphography in mice with gadopentetate dimeglumine and gadoxetate disodium
  publication-title: J Magn Reson Imaging
– volume: 28
  start-page: 273
  year: 2010
  end-page: 280
  article-title: Diet and gastrointestinal signal on T1‐weighted magnetic resonance imaging of mice
  publication-title: Magn Reson Imaging
– volume: 21
  start-page: 5831
  year: 2015
  end-page: 5842
  article-title: Magnetic resonance imaging of the pancreas in streptozotocin‐induced diabetic rats: Gadofluorine P and Gd‐DOTA
  publication-title: World J Gastroenterol
– volume: 6
  start-page: 109
  year: 2008
  end-page: 122
  article-title: The lymphatic system in health and disease
  publication-title: Lymphat Res Biol
– volume: 218
  start-page: 664
  year: 2001
  end-page: 669
  article-title: Interstitial MR lymphography with a conventional extracellular gadolinium‐based agent: assessment in rabbits
  publication-title: Radiology
– volume: 9
  start-page: 2539
  year: 2014
  end-page: 2555
  article-title: Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect
  publication-title: Int J Nanomed
– volume: 37
  start-page: 295
  year: 1999
  end-page: 312
  article-title: Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography
  publication-title: Adv Drug Deliv Rev
– volume: 45
  start-page: 1016
  year: 2007
  end-page: 1021
  article-title: Preliminary experience with a novel fluorescence lymphography using indocyanine green in patients with secondary lymphedema
  publication-title: J Vasc Surg
– volume: 27
  start-page: 641
  year: 2003
  end-page: 646
  article-title: Interstitial magnetic resonance lymphography: comparative animal study of gadofluorine 8 and gadolinium diethylenetriamine‐pentaacetic acid
  publication-title: J Comput Assist Tomogr
– volume: 11
  start-page: 99
  year: 2012
  end-page: 107
  article-title: Interstitial MR lymphography in mice: comparative study with gadofluorine 8, gadofluorine M, and gadofluorine P
  publication-title: Magn Reson Med Sci
– volume: 148
  start-page: 160
  year: 2010
  end-page: 167
  article-title: Polyion complex micelle MRI contrast agents from poly(ethylene glycol)‐b‐poly(l‐lysine) block copolymers having Gd‐DOTA; preparations and their control of T(1)‐relaxivities and blood circulation characteristics
  publication-title: J Control Release
– volume: 58
  start-page: 375
  year: 2006
  end-page: 382
  article-title: MR contrast agents in lymph node imaging
  publication-title: Eur J Radiol
– volume: 15
  start-page: 213
  year: 2015
  article-title: Sentinel lymph node detection using magnetic resonance lymphography with conventional gadolinium contrast agent in breast cancer: a preliminary clinical study
  publication-title: BMC Cancer
– volume: 98
  start-page: 413
  year: 2003
  end-page: 423
  article-title: Insights into the mechanisms of lymph node metastasis
  publication-title: Cancer
– ident: e_1_2_5_12_1
  doi: 10.1016/S0169-409X(98)00099-4
– ident: e_1_2_5_7_1
  doi: 10.1016/j.jvs.2007.01.023
– volume: 46
  start-page: 6387
  year: 1986
  ident: e_1_2_5_23_1
  article-title: A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
  publication-title: Cancer Res
  contributor:
    fullname: Matsumura Y
– ident: e_1_2_5_6_1
  doi: 10.1038/nbt920
– ident: e_1_2_5_11_1
  doi: 10.1148/radiol.2203010090
– ident: e_1_2_5_2_1
  doi: 10.1002/cncr.11464
– ident: e_1_2_5_21_1
  doi: 10.3748/wjg.v21.i19.5831
– ident: e_1_2_5_3_1
  doi: 10.1089/lrb.2008.1008
– ident: e_1_2_5_10_1
  doi: 10.1002/jmri.1880070111
– ident: e_1_2_5_4_1
  doi: 10.1016/j.ejrad.2005.12.044
– ident: e_1_2_5_16_1
  doi: 10.2463/mrms.11.99
– ident: e_1_2_5_20_1
  doi: 10.1148/radiology.218.3.r01fe21664
– ident: e_1_2_5_8_1
  doi: 10.1148/radiol.2302021380
– ident: e_1_2_5_14_1
  doi: 10.1097/00004728-200307000-00036
– ident: e_1_2_5_22_1
– ident: e_1_2_5_17_1
  doi: 10.1016/j.jconrel.2009.01.010
– ident: e_1_2_5_5_1
  doi: 10.1097/01.rli.0000065423.05038.88
– volume: 9
  start-page: 2539
  year: 2014
  ident: e_1_2_5_24_1
  article-title: Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect
  publication-title: Int J Nanomed
  contributor:
    fullname: Nehoff H
– ident: e_1_2_5_13_1
  doi: 10.1186/s12885-015-1255-4
– ident: e_1_2_5_18_1
  doi: 10.1016/j.jconrel.2010.08.018
– ident: e_1_2_5_19_1
  doi: 10.1016/j.mri.2009.10.005
– ident: e_1_2_5_15_1
  doi: 10.1002/jmri.22422
– ident: e_1_2_5_9_1
  doi: 10.1097/00004424-200302000-00002
SSID ssj0009945
Score 2.3607137
Snippet Purpose To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)‐b‐poly(L‐lysine‐DOTA) (Gd‐micelle) as a contrast agent for magnetic...
To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)-b-poly(L-lysine-DOTA) (Gd-micelle) as a contrast agent for magnetic resonance...
Purpose To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)-b-poly(L-lysine-DOTA) (Gd-micelle) as a contrast agent for magnetic...
PURPOSETo investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)-b-poly(L-lysine-DOTA) (Gd-micelle) as a contrast agent for magnetic...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 238
SubjectTerms Animals
Aorta
Area Under Curve
Biopsy
contrast agent
Contrast agents
Contrast Media - chemistry
Coordination Complexes - chemistry
Factorial analysis
Feasibility Studies
Female
Fluorocarbons - chemistry
Freund's Adjuvant
Gadolinium
Gadolinium - chemistry
Image Processing, Computer-Assisted
Inflammation
Lymph nodes
Lymph Nodes - diagnostic imaging
Lymphatic system
Lymphography
Lysine
Magnetic Resonance Imaging
Mice
Mice, Inbred BALB C
Micelles
MR lymphography
Polyethylene glycol
Polyethylene Glycols - chemistry
Polylysine - chemistry
Qualitative analysis
Sacrum
Variance analysis
Title PEG‐poly(L‐lysine)‐based polymeric micelle MRI contrast agent: Feasibility study of a Gd‐micelle contrast agent for MR lymphography
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmri.25740
https://www.ncbi.nlm.nih.gov/pubmed/28419613
https://www.proquest.com/docview/1975482327
https://search.proquest.com/docview/1889779909
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VPaBeeLQ8AgW5KgdAyjaJndhGXKo-qViEKir1giInsVXoNrvq7h7KiTuX_sb-ks44ya6WSkhws-TYjj0zns_2-DPAaxkJpw2XITojG4qSi9BYEYdFZKSrEie0orvD_c_Z4Yk4Ok1Pl-BDdxem4YeYbbiRZfj5mgzcFOOtOWnoj4vL7z1UOEEL9phLiufaPZ5zR2ntXyhG_MDDWEVyxk2abM2LLnqjOxBzEbF6l7P_AL51P9tEmpz3ppOiV_78g8fxf3vzEO63WJRtN8rzCJZsvQr3-u1p-xr8_rJ3cPPrejQcXL35hAliL6ntW0yR76sYZfgDH0Zv2g8GlvWPPzIf_G7GE2bo1tZ7hiCzDcG9Yp7Mlg0dM-ygwnq6cotlGAJprIph7aOzllL7MZzs733dOQzbxxvCUqQ6QmGn1sRVoiwxvhmKZ3EC9QJXWFkpVGV1SUe2WnKOEK7iKSIJboxDeFdGymX8CSzXw9o-A2aIwy6zSspMi6hIEeEQTaGLnE2MEVkAm50Q81HD0ZE3bMxJTuOa-3ENYL2Tb97a6TiPtcQlG6JKGcDGLBstjHpvajuc4jdKIUhGr60DeNroxawZdO44hcU8gHdeun9pPz9CGfjU83_5-AWsIEZTza7POixPLqf2JeKgSfHK6_sthOkGWg
link.rule.ids 315,783,787,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VrVS4UMozfWEEB0DKNomd2OZW9bUtuxWqWqm3yJvYomXJrrq7h3LizoXfyC9hxsnuakFCgpul-CFnZjyf7fE3AK9lJJw2XIbojGwoCi5CY0Uc9iIjXZk4oRW9He6eZe1LcXqVXjWxOfQWpuaHmB24kWX49ZoMnA6kd-esoTdfbq9bqHECd-wraO-cMjccnM_Zo7T2OYoRQfAwVpGcsZMmu_O2i_7oD5C5iFm90zlaqzOrjjxXIcWafG5Nxr1W8fU3Jsf_ns9DeNDAUbZX6886LNnqEax2mwv3x_D94-Hxz28_hoP-3ZsOFojApLJvsUTur2T0wd_5MEpr3-9b1j0_YT7-3YzGzNDDrfcMcWYThXvHPJ8tGzhm2HGJ_UzbLbZhiKWxK4a9Dz81rNpP4PLo8GK_HTb5G8JCpDpCeafWxGWiLJG-GQppcQJVAzdZWSFUaXVBt7Zaco4oruQpgglujEOEV0TKZfwpLFeDyj4HZojGLrNKykyLqJciyCGmQhc5mxgjsgBeTaWYD2uajrwmZE5y-q-5_68BbE0FnDemOspjLXHXhsBSBvBy9hmNjGZvKjuYYB2lECej49YBPKsVYzYM-ndcxWIewDsv3r-Mn5-iDHxp418qv4B77YtuJ--cnH3YhPsI2VR9CLQFy-Pbid1GWDTu7Xjl_wXJiwpy
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hkBCXFvoMLNQVPdBKWZLYiW3EpWpZnosQKhIXFHkTWzyW7IrdPcCJOxd-Y39Jx06yq22lSu3NkmM79sx4PtvjzwCfeMCMVJT76Iy0zzLKfKVZ6HcCxU0eGSaFvTvcPk72ztjBeXw-A9v1XZiSH2K84WYtw83X1sD7udmckIZe395dNVHhGC7Y51iC0NdCotMJeZSU7oliBBDUD0XAx-Sk0eak7LQ7-gNjTkNW53NaL-Gi_tsy1OSmORp2mtnDb0SO_9udRXhRgVHytdSeJZjRxSuYb1fH7a_h6WRn9-fjc7_Xvd84woSlLyn0Z0xZ55cTm-FOfIh91L7b1aR9uk9c9LsaDImy17a2CKLMKgb3njg2W9IzRJHdHOupy02XIYiksSqCtfcvK07tN3DW2vnxbc-vXm_wMxbLAKUdaxXmkdCW8k3ZgBbDUDFwiZVkTORaZvbMVnJKEcPlNEYoQZUyiO-yQJiEvoXZolfo90CUJbFLtOA8kSzoxAhxLE-hCYyOlGKJB-u1ENN-SdKRlnTMUWrHNXXj6kGjlm9aGeogDSXHNRvCSu7Bx3E2mpjtvSp0b4TfCIEoGd229OBdqRfjZtC74xwWUg--OOn-pf30AGXgUsv_8vEHmD_53kqP9o8PV2AB8Zood4AaMDu8G-lVxETDzppT_V-vEgkh
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PEG-poly%28L-lysine%29-based+polymeric+micelle+MRI+contrast+agent%3A+Feasibility+study+of+a+Gd-micelle+contrast+agent+for+MR+lymphography&rft.jtitle=Journal+of+magnetic+resonance+imaging&rft.au=Akai%2C+Hiroyuki&rft.au=Shiraishi%2C+Kouichi&rft.au=Yokoyama%2C+Masayuki&rft.au=Yasaka%2C+Koichiro&rft.date=2018-01-01&rft.eissn=1522-2586&rft.volume=47&rft.issue=1&rft.spage=238&rft_id=info:doi/10.1002%2Fjmri.25740&rft_id=info%3Apmid%2F28419613&rft.externalDocID=28419613
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-1807&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-1807&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-1807&client=summon